Other Viruses Citation List:
December 9 - December 22, 2011
Hepatitis A virus
1. Functional Binding of Hexanucleotides to 3C Protease of Hepatitis A Virus. Blaum, B.S., W. Wunsche, A.J. Benie, Y. Kusov, H. Peters, V. Gauss-Muller, T. Peters, and G. Sczakiel, Nucleic Acids Research, 2011. [Epub ahead of print]; PMID[22156376].
[PubMed]. OV_1209-122211.
Hepatitis C virus
2. A Cell-permeable Hairpin Peptide Inhibits Hepatitis C Viral Nonstructural Protein 5A Mediated Translation and Virus Production. Khachatoorian, R., V. Arumugaswami, P. Ruchala, S. Raychaudhuri, E.M. Maloney, E. Miao, A. Dasgupta, and S.W. French, Hepatology (Baltimore, Md.), 2011. [Epub ahead of print]; PMID[22183951].
[PubMed]. OV_1209-122211.
3. Novel Substituted Pyrimidines as HCV Replication (replicase) Inhibitors. Kwong, C.D., J.L. Clark, A.T. Fowler, F. Geng, H.S. Kezar, 3rd, A. Roychowdhury, R.C. Reynolds, J.A. Maddry, S. Ananthan, J.A. Secrist, 3rd, N.Y. Shih, J.J. Piwinski, C. Li, B. Feld, H.C. Huang, X. Tong, F. George Njoroge, and A. Arasappan, Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[22178556].
[PubMed]. OV_1209-122211.
4. Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites. Abbas, S., M. Kelly, J. Bowling, J. Sims, A. Waters, and M. Hamann, Marine drugs, 2011. 9(11): p. 2423-2437; PMID[22163194].
[PubMed]. OV_1209-122211.
5. A Macrocyclic HCV NS3/4A Protease Inhibitor Interacts with Protease and Helicase Residues in the Complex with its Full-length Target. Schiering, N., A. D'Arcy, F. Villard, O. Simic, M. Kamke, G. Monnet, U. Hassiepen, D.I. Svergun, R. Pulfer, J. Eder, P. Raman, and U. Bodendorf, Proceedings of the National Academy of Sciences of the United States of America, 2011. [Epub ahead of print]; PMID[22160684].
[PubMed]. OV_1209-122211.
6. Pharmacodynamic Analysis of a Serine Protease Inhibitor (MK-4519) on Hepatitis C Virus Using a Novel in Vitro Pharmacodynamic System. Brown, A.N., J.J. McSharry, J.R. Adams, R. Kulawy, R.J. Barnard, W. Newhard, A. Corbin, D.J. Hazuda, A. Louie, and G.L. Drusano, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[22155837].
[PubMed]. OV_1209-122211.
7. Structure-Activity-Relationship Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus NS5B Polymerase. Chen, K.X., B. Vibulbhan, W. Yang, M. Sannigrahi, F. Velazquez, T.Y. Chan, S. Venkatraman, G.N. Anilkumar, Q. Zeng, F. Bennet, Y. Jiang, C.A. Lesburg, J. Duca, P. Pinto, S. Gavalas, Y. Huang, W. Wu, O. Selyutin, S. Agrawal, B. Feld, H.C. Huang, C. Li, K.C. Cheng, N.Y. Shih, J.A. Kozlowski, S.B. Rosenblum, and F.G. Njoroge, Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[22148957].
[PubMed]. OV_1209-122211.
Herpes Simplex Virus 2
8. The anti-HSV-2 Effect of Alumen: In Vitro and in Vivo Experimental Studies. Hong, L., X. Xu, L. Chen, B. Li, D. Wu, M. Hu, Q. Sun, X. Zhu, W. Wu, S. Hong, W. Ding, J. Min, and Q. Xu, Journal of Huazhong University of Science and Technology, 2011. 31(6): p. 828-833; PMID[22173507].
[PubMed]. OV_1209-122211.
9. Efficacy of ASP2151, a Helicase-primase Inhibitor, against Thymidine Kinase-deficient Herpes Simplex Virus Type 2 Infection in Vitro and in Vivo. Himaki, T., Y. Masui, K. Chono, T. Daikoku, M. Takemoto, B. Haixia, T. Okuda, H. Suzuki, and K. Shiraki, Antiviral Research, 2011. [Epub ahead of print]; PMID[22155691].
[PubMed]. OV_1209-122211.
SIV
10. Suppression of Immunodeficiency Virus-Associated Neural Damage by the p75 Neurotrophin Receptor Ligand, LM11A-31, in an In Vitro Feline Model. Meeker, R.B., W. Poulton, W.H. Feng, L. Hudson, and F.M. Longo, Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology, 2011. [Epub ahead of print]; PMID[22161560].
[PubMed]. OV_1209-122211.
Citations from the ISI Web of Knowledge Listings for O.V.
11. Quinoline Tricyclic Derivatives. Design, Synthesis and Evaluation of the Antiviral activity of Three New Classes of RNA-dependent RNA Polymerase Inhibitors. Carta, A., I. Briguglio, S. Piras, P. Corona, G. Boatto, M. Nieddu, P. Giunchedi, M.E. Marongiu, G. Giliberti, F. Iuliano, S. Blois, C. Ibba, B. Busonera, and P. La Colla, Bioorganic & Medicinal Chemistry, 2011. 19(23): p. 7070-7084; ISI[000296752300013].
[WOS]. OV_1209-122211.
12. Inhibition of Hepatitis C Virus Replication Through Adenosine Monophosphate-activated Protein Kinase-dependent and -independent Pathways. Nakashima, K., K. Takeuchi, K. Chihara, H. Hotta, and K. Sada, Microbiology and Immunology, 2011. 55(11): p. 774-782; ISI[000297294300004].
[WOS]. OV_1209-122211.
13. Effects of New Quinizarin Derivatives on Both HCV NS5B RNA Polymerase and HIV-1 Reverse Transcriptase Associated Ribonuclease H Activities.Tramontano, E., T. Kharlamova, L. Zinzula, and F. Esposito, Journal of Chemotherapy, 2011. 23(5): p. 273-276; ISI[000297189900004].
[WOS]. OV_1209-122211.